On Tuesday, Ideaya Biosciences Inc (NASDAQ: IDYA) opened higher 4.24% from the last session, before settling in for the closing price of $21.71. Price fluctuations for IDYA have ranged from $13.45 to $44.42 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 4.48% at the time writing. With a float of $78.78 million, this company’s outstanding shares have now reached $87.57 million.
Let’s look at the performance matrix of the company that is accounted for 131 employees. In terms of profitability, gross margin is 75.14%, operating margin of -5147.81%, and the pretax margin is -4375.86%.
Ideaya Biosciences Inc (IDYA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ideaya Biosciences Inc is 10.05%, while institutional ownership is 101.36%. The most recent insider transaction that took place on Aug 26 ’24, was worth 3,016,500.
Ideaya Biosciences Inc (IDYA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 4.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.56% during the next five years compared to -0.01% drop over the previous five years of trading.
Ideaya Biosciences Inc (NASDAQ: IDYA) Trading Performance Indicators
Check out the current performance indicators for Ideaya Biosciences Inc (IDYA). In the past quarter, the stock posted a quick ratio of 13.92. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 283.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.59, a number that is poised to hit -0.79 in the next quarter and is forecasted to reach -2.99 in one year’s time.
Technical Analysis of Ideaya Biosciences Inc (IDYA)
Ideaya Biosciences Inc (NASDAQ: IDYA) saw its 5-day average volume 1.0 million, a negative change from its year-to-date volume of 1.2 million. As of the previous 9 days, the stock’s Stochastic %D was 85.00%. Additionally, its Average True Range was 1.08.
During the past 100 days, Ideaya Biosciences Inc’s (IDYA) raw stochastic average was set at 75.62%, which indicates a significant decrease from 90.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.53% in the past 14 days, which was lower than the 60.34% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.44, while its 200-day Moving Average is $24.85.
